Form 4 for ISRG Intuitive Surgical
Accepted 2025-03-06 00:00:00 ET · period of report 2025-03-05 · accession 0001035267-25-000080 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-03-06 | 2025-03-05 | ISRG | Rosa David J. | Pres, Dir | S - Sale+OE | $557.52 | -16.5K | 225.4K | -7% | -$9.20M |
| DM | 2025-03-06 | 2025-03-05 | ISRG | Rosa David J. | Pres, Dir | M - OptEx | $68.23 | +29.2K | 233.8K | +14% | +$2.00M |
| DM | 2025-03-06 | 2025-03-05 | ISRG | Rosa David J. | Pres, Dir | M - OptEx | $0.00 | -29.2K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-03-05 | S | D | 8,140 | $557.58 | 231,923 | D | — | — | (F3) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $554.17 to $567.89 as follows: 1,305 shares sold at $554.17 to $554.57; 1,751 shares sold at $556.44 to $557.42; 2,133 shares sold at $557.51 to $558.28; 2,748 shares sold at $558.52 to $559.37; 100 shares sold at $559.63; and 103 shares sold at $567.89. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2025-03-05 | M | A | 14,625 | $59.46 | 240,063 | D | — | — | |
| 3 | Common | Common Stock | 2025-03-05 | M | A | 14,625 | $77.00 | 233,807 | D | — | — | |
| 4 | Common | Common Stock | 2025-03-05 | S | D | 8,369 | $557.47 | 225,438 | D | — | — | (F2) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $554.17 to $567.89 as follows: 1,466 shares sold at $554.17 to $554.79; 2,122 shares sold at $556.44 to $557.39; 1,968 shares sold at $557.51 to $558.35; 2,663 shares sold at $558.58 to $559.38; 100 shares sold at $559.63; and 50 shares sold at $567.89. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 5 | Derivative | Non-Qualified Stock Option (right to buy) | 2025-03-05 | M | D | 14,625 | $0.00 | 0 | D | $77.00 · — to 2026-08-15 | 14,625 Common Stock | (F5) Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter. |
| 6 | Derivative | Non-Qualified Stock Option (right to buy) | 2025-03-05 | M | D | 14,625 | $0.00 | 0 | D | $59.46 · — to 2026-02-16 | 14,625 Common Stock | (F4) Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. |